BLLN Q2 revenue rises 64% with strong margins and oncology growth
BLLN reported 64% Q2 revenue growth and strong profitability, driven by gains in prenatal and oncology. The company said independent clinics drive most growth, while health system integration investments and new products are set to accelerate expansion.
Q2 revenue grew 64%, with profitability remaining strong and growth led by steady gains in prenatal and oncology businesses. Most of the expansion still comes from independent clinics, while investment in health system integration and new products is expected to speed growth. Oncology is scaling rapidly and carries high gross margins, an…